Recent News

• 04.17.2025 - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
• 04.17.2025 - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
• 03.19.2025 - XORTX Announces Update for Discussion with the FDA
• 03.19.2025 - XORTX Announces Update for Discussion with the FDA
• 02.24.2025 - XORTX Commences Gout Program NDA Discussions with the FDA
• 02.24.2025 - XORTX Commences Gout Program NDA Discussions with the FDA
• 01.29.2025 - XORTX to Present at Microcap Conference
• 01.29.2025 - XORTX to Present at Microcap Conference

Recent Filings

• 04.01.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.26.2025 - EX-99.1 EX-99.1
• 03.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.19.2025 - EX-99.1 EX-99.1
• 03.19.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.24.2025 - EX-99.1 EX-99.1
• 02.24.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.29.2025 - EX-99.1 EX-99.1